Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

IOVA

Iovance Biotherapeutics Inc

Jun 14 • 04:00PM ET

8.16

Dollar change -0.27
Percentage change -3.20	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB VBR IWM VXF XBI IWN IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.82	Insider Own	20.06%	Shs Outstand	256.14M	Perf Week	4.88%
Market Cap	2.28B	Forward P/E	-	EPS next Y	-0.70	Insider Trans	10.39%	Shs Float	223.70M	Perf Month	-23.60%
Income	-449.64M	PEG	-	EPS next Q	-0.34	Inst Own	68.48%	Short Float	22.34%	Perf Quarter	-41.34%
Sales	1.90M	P/S	1201.80	EPS this Y	32.19%	Inst Trans	-1.91%	Short Ratio	8.44	Perf Half Y	11.02%
Book/sh	2.43	P/B	3.36	EPS next Y	45.38%	ROA	-53.07%	Short Interest	49.96M	Perf Year	-5.88%
Cash/sh	1.27	P/C	6.41	EPS next 5Y	-	ROE	-66.77%	52W Range	3.21 - 18.33	Perf YTD	0.37%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-8.25%	ROI	-59.69%	52W High	-55.48%	Beta	0.64
Dividend TTM	-	Quick Ratio	4.42	Sales past 5Y	0.00%	Gross Margin	-2251.94%	52W Low	154.21%	ATR (14)	0.66
Dividend Ex-Date	-	Current Ratio	4.63	EPS Y/Y TTM	24.46%	Oper. Margin	-24549.63%	RSI (14)	31.54	Volatility	8.75% 6.58%
Employees	557	Debt/Eq	0.12	Sales Y/Y TTM	-	Profit Margin	-23615.70%	Recom	1.31	Target Price	25.18
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	15.53%	Payout	-	Rel Volume	1.08	Prev Close	8.43
Sales Surprise	-64.76%	EPS Surprise	1.01%	Sales Q/Q	-	Earnings	May 09 AMC	Avg Volume	5.92M	Price	8.16
SMA20	-10.89%	SMA50	-26.11%	SMA200	-7.19%	Trades		Volume	6,402,978	Change	-3.20%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Initiated	Goldman	Buy	$12
Sep-18-23	Reiterated	Barclays	Overweight	$40 → $18
May-30-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$11 → $17
Mar-27-23	Resumed	Wells Fargo	Equal Weight	$11
Jan-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$11 → $14
Dec-09-22	Downgrade	Goldman	Buy → Neutral	$20 → $6
Oct-31-22	Initiated	Guggenheim	Neutral
Aug-18-22	Resumed	Wells Fargo	Equal Weight	$14
Jan-28-22	Upgrade	Stifel	Hold → Buy	$23 → $25
Dec-07-21	Resumed	Cowen	Outperform
Jun-10-21	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$32
May-20-21	Downgrade	Piper Sandler	Overweight → Neutral	$35 → $18
May-19-21	Downgrade	Stifel	Buy → Hold
May-19-21	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
May-03-21	Initiated	Truist	Buy	$50
Apr-16-21	Initiated	Goldman	Buy	$97
Mar-08-21	Upgrade	H.C. Wainwright	Neutral → Buy	$50
Dec-15-20	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-06-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-22-20	Initiated	Mizuho	Buy	$61

Show Previous Ratings

Jun-10-24 10:15AM	The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why (Motley Fool)
May-29-24 06:20AM	What Makes e.l.f. Beauty (ELF) an Investment Bet? (Insider Monkey)
04:58AM	Should You Consider Adding SharkNinja (SN) to Your Portfolio? (Insider Monkey)
May-28-24 08:14AM	Iovance Biotherapeutics (IOVA) Shares Rallied after the FDA approval of AMTAGVI (Insider Monkey)
08:06AM	Artisan Partners Small Cap Fund Trimmed Wingstop (WING) Based on Valuation Discipline (Insider Monkey)
04:01PM	Loading…
May-24-24 04:01PM	Iovance Biotherapeutics to Present at Upcoming Conferences and Events (GlobeNewswire)
11:18AM	Iovance (IOVA) Up 5% on Updated Data From Melanoma Study (Zacks)
May-23-24 05:00PM	Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting (GlobeNewswire)
May-22-24 06:40AM	Bull Market Buys: 2 Growth Stocks to Own for the Long Run (Motley Fool)
May-17-24 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
May-16-24 09:30AM	4 Small-Cap Value Stocks That Could Go Parabolic (Motley Fool)
May-13-24 02:25PM	Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained (MT Newswires)
12:42PM	Truist Adjusts Iovance Biotherapeutics' Price Target to $25 From $26, Keeps Buy Rating (MT Newswires)
May-11-24 10:00AM	The 3 Most Undervalued Biotech Stocks to Buy in May 2024 (InvestorPlace)
May-10-24 02:03PM	Why Iovance Stock Is Down 18% Today (Motley Fool) -18.48%
01:35PM	Loading…
01:35PM	Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says (MT Newswires)
12:55PM	Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ... (GuruFocus.com)
12:33PM	Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:25AM	Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates (MT Newswires)
10:58AM	Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates (Zacks)
May-09-24 08:57PM	IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:27PM	Iovance Biotherapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:23PM	Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours (MT Newswires)
04:01PM	Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates (GlobeNewswire)
May-06-24 09:56AM	Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect (Zacks)
May-01-24 06:01AM	Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024 (GlobeNewswire) +6.11%
Apr-30-24 06:01AM	Iovance Biotherapeutics to Present at Upcoming Conferences (GlobeNewswire)
Apr-28-24 02:44PM	Where Will Iovance Biotherapeutics Stock Be in 5 Years? (Motley Fool)
Apr-27-24 07:00AM	The Top 3 Biotech Stocks to Buy in April 2024 (InvestorPlace)
Apr-25-24 10:30AM	3 Millionaire-Maker Biotech Stocks (Motley Fool)
09:20AM	Loading…
09:20AM	20 Counties with the Highest Cancer Rates in the US (Insider Monkey)
Apr-24-24 04:01PM	Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting (GlobeNewswire)
Apr-21-24 05:08AM	These Biotech Stocks Could Soar 120% and 295%, According to Wall Street (Motley Fool)
Apr-19-24 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-17-24 09:45AM	Is Iovance Biotherapeutics Stock a Buy Now? (Motley Fool)
Apr-08-24 01:51PM	Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why (Zacks)
Apr-05-24 05:03AM	Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics (Motley Fool)
Mar-29-24 11:30AM	Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-26-24 04:11AM	2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street (Motley Fool)
Mar-23-24 09:00AM	U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (The Wall Street Journal)
Mar-22-24 05:30PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-18-24 08:01PM	7 Biotech Stocks Ready to Ride the Sectors Resurgence (InvestorPlace)
02:00AM	Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead (Motley Fool)
Mar-15-24 08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Mar-07-24 06:01AM	1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17? (Motley Fool)
Mar-06-24 04:42AM	Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst (Motley Fool)
Mar-05-24 01:00PM	FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study (Zacks)
Mar-04-24 06:30AM	Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer (GlobeNewswire)
Mar-02-24 06:50AM	Could Iovance Biotherapeutics Stock Help You Become a Millionaire? (Motley Fool)
Mar-01-24 05:00PM	Iovance Biotherapeutics to Present at Upcoming Conferences (GlobeNewswire) +5.53%
Feb-29-24 05:47PM	Why Iovance Biotherapeutics Stock Got Trounced on Thursday (Motley Fool) -8.72%
12:17PM	Q4 2023 Iovance Biotherapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
10:37AM	Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates (Zacks)
09:44AM	Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:51AM	Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy? (Motley Fool)
Feb-28-24 05:35PM	Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:42PM	Iovance Biotherapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:35PM	Iovance Biotherapeutics Inc (IOVA) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com)
04:01PM	Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates (GlobeNewswire)
Feb-27-24 08:52AM	Why Iovance (IOVA) Might Surprise This Earnings Season (Zacks) +5.24%
Feb-26-24 05:39AM	1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street (Motley Fool) +5.26%
Feb-25-24 08:07AM	Insiders Pour Millions Into These 2 Buy-Rated Stocks; Heres Why You Might Want to Follow Their Lead (TipRanks)
05:01AM	Is Iovance a Buy After Its First Regulatory Win? (Motley Fool)
Feb-23-24 06:14AM	This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst (Motley Fool)
Feb-22-24 08:45AM	Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024 (GlobeNewswire)
04:00AM	13 Best Short Squeeze Stocks To Buy Now (Insider Monkey)
Feb-20-24 03:38PM	Iovance Biotherapeutics Stock Rockets 30% Higher (Barrons.com) +31.48%
11:02AM	Why Iovance Biotherapeutics Stock Is Skyrocketing Today (Motley Fool)
08:00AM	WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI (lifileucel) for Advanced Melanoma (PR Newswire)
06:30AM	Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock (GlobeNewswire)
Feb-19-24 08:36AM	Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi (Zacks)
Feb-16-24 05:30PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) -7.29%
04:04PM	UPDATE 3-US FDA grants accelerated approval for Iovance's skin cancer cell therapy (Reuters)
03:38PM	Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024 (GlobeNewswire)
03:35PM	FDA approves Iovance Biotherapeutics cell therapy for skin cancer (Reuters)
03:19PM	Iovance's AMTAGVI (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma (GlobeNewswire)
Feb-12-24 07:14AM	3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk (Motley Fool) +8.39%
Feb-08-24 07:27AM	Is Iovance Biotherapeutics Stock a Buy Now? (Motley Fool) +7.56%
Feb-07-24 05:10AM	Is Iovance Biotherapeutics a Buy Before This Key FDA Decision? (Motley Fool)
Feb-05-24 05:25AM	A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist (Motley Fool)
Feb-04-24 06:27AM	What's Next for Iovance Biotherapeutics Stock? (Motley Fool)
Jan-19-24 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-15-24 12:27PM	Iovance (IOVA) Surges More Than 150% in 3 Months: Here's Why (Zacks)
Jan-08-24 05:31AM	2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street (Motley Fool) +12.87%
Dec-28-23 05:59PM	Why Iovance Biotherapeutics Stock Popped Today (Motley Fool) +18.67%
11:13AM	Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug (Zacks)
08:01AM	3 Charts For Investors to Watch Thursday: GC Education, Iovance, Ethereum (Investopedia)
Dec-27-23 05:26PM	Gold nears $2100, biotech stocks on the move: Trending tickers (Yahoo Finance Video) -18.67%
02:02PM	Iovance Stock Plunges on FDA News (Barrons.com)
12:21PM	Cytokinetics, New York Times rise; Iovance Biotherapeutics fall, Wednesday, 12/27/2023 (Associated Press Finance)
12:21PM	FDA Slaps Clinical Hold On Iovance Biotherapeutics' Lung Cancer Study After Patient Death (Benzinga)
11:21AM	Iovance Plummets as FDA Halts Cancer Drug Trial After Death (Bloomberg)
10:41AM	Iovance plunges as FDA halts lung-cancer-drug trial after patient death (TheStreet.com)
09:57AM	Iovance Stock Plunges as FDA Puts Hold on Lung Cancer Study After Patient Death (Barrons.com)
07:06AM	US FDA places clinical hold on Iovance's lung cancer treatment trial (Reuters)
07:00AM	Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer (GlobeNewswire)
Dec-22-23 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +5.70%
Dec-18-23 02:58PM	12 Most Promising Cancer Stocks According to Analysts (Insider Monkey)
Dec-12-23 08:45AM	Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? (Motley Fool)
05:29AM	A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street (Motley Fool)

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007, and is headquartered in San Carlos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Jun 03 '24	Option Exercise	0.00	3,906	0	46,468	Jun 05 08:07 PM
BILINSKY IGOR	Chief Operating Officer	Jun 03 '24	Option Exercise	0.00	3,516	0	41,542	Jun 05 08:05 PM
Vogt Frederick G	Interim CEO & General Counsel	Jun 03 '24	Option Exercise	0.00	10,417	0	151,751	Jun 05 08:04 PM
Vogt Frederick G	Interim CEO & General Counsel	Apr 15 '24	Option Exercise	0.00	20,834	0	150,185	Apr 17 07:08 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Apr 15 '24	Option Exercise	0.00	2,812	0	43,989	Apr 17 07:07 PM
BILINSKY IGOR	Chief Operating Officer	Apr 15 '24	Option Exercise	0.00	2,812	0	39,453	Apr 17 07:07 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Mar 04 '24	Option Exercise	0.00	15,623	0	49,230	Mar 06 06:20 PM
Vogt Frederick G	Interim CEO & General Counsel	Mar 04 '24	Option Exercise	0.00	41,662	0	140,800	Mar 06 06:19 PM
Rothbaum Wayne P.	Director	Feb 20 '24	Buy	9.15	5,000,000	45,750,000	28,067,333	Feb 20 04:11 PM
MCPEAK MERRILL A	Director	Feb 20 '24	Buy	9.15	250,000	2,287,500	320,150	Feb 20 07:52 PM
Dukes Iain D.	Director	Feb 20 '24	Buy	9.15	32,000	292,800	54,000	Feb 20 04:21 PM
Vogt Frederick G	Interim CEO & General Counsel	Jan 16 '24	Option Exercise	0.00	20,834	0	105,668	Jan 18 06:09 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Jan 16 '24	Option Exercise	0.00	2,813	0	35,184	Jan 18 06:09 PM
BILINSKY IGOR	Chief Operating Officer	Jan 16 '24	Option Exercise	0.00	2,813	0	31,444	Jan 18 06:07 PM
Vogt Frederick G	Interim CEO & General Counsel	Oct 16 '23	Option Exercise	0.00	20,835	0	93,685	Oct 18 08:05 PM
BILINSKY IGOR	Chief Operating Officer	Oct 16 '23	Option Exercise	0.00	2,813	0	30,026	Oct 18 08:04 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Oct 16 '23	Option Exercise	0.00	2,813	0	33,766	Oct 18 08:03 PM
MCPEAK MERRILL A	Director	Sep 18 '23	Buy	5.56	10,000	55,600	248,633	Sep 19 04:30 PM
Rothbaum Wayne P.	Director	Sep 15 '23	Buy	5.30	5,000,000	26,500,000	23,067,333	Sep 15 06:12 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Jul 14 '23	Option Exercise	0.00	2,813	0	32,348	Jul 17 06:22 PM
Vogt Frederick G	Interim CEO & General Counsel	Jul 14 '23	Option Exercise	0.00	20,834	0	81,701	Jul 17 06:22 PM
BILINSKY IGOR	Chief Operating Officer	Jul 14 '23	Option Exercise	0.00	2,813	0	28,608	Jul 17 06:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IOVA

Iovance Biotherapeutics Inc

Upgrade your FINVIZ experience